4-(3,5-Dimethyl-1H-pyrazol-4-yl)benzoic acid, 97%, 250mg

(2E)-3-(3-fluorophenyl)-1-(4-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 2g

2-((5-(Benzo[d][1,3]dioxol-5-yl)-1,3,4-oxadiazol-2-yl)thio)acetic acid, 100mg

4-(2-methylpyrimidin-4-yl)aniline, 50mg

tert-Butyl 4-oxo-3-azatricyclo[4.2.1.02,5]non-7-ene-3-carboxylate, 95%, 1g

1-[4-(4-CHLORANYLPHENOXY)PHENYL]UREA, 95.0%, 250mg

6-Amino-3H-quinazolin-4-one, 95.0%, 5g

(R)-(-)-NBD-APy [=(R)-(-)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

2-(Azetidin-3-yl)propan-2-ol, 98%, 1g

2-Amino-4-nitrophenol Sodium Salt>80.0%(HPLC)(T)25g

2-Bromo-2,3,3,3-tetrafluoropropionyl fluoride, 97.0%, 1g

5-Chloro-2,3-diphenylpyrazine, 95.0%, 5g